NIH-funded research R01 grant

Brain–Liver Axis in Cancer-Associated Cachexia: A New Way to Help People with Advanced Cancer

Official title: Deciphering the Brain–Liver Axis in Cancer-Associated Cachexia

Funded at University of Tx Md Anderson Can Ctr · NIH-11425280 · Data updated 2026-11-12

A new approach targets the brain–liver link to treat cancer-related weight loss and muscle wasting in people with advanced cancer.

More Cachexia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 13, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$537,531
NIH project number1R01CA315660-01
Project IDNIH-11425280 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with advanced cancers (especially pancreatic, gastrointestinal, or lung) who are experiencing or at risk for cancer-associated cachexia.

Less likely to help

Patients without cachexia or those unable to participate in non-invasive neuromodulation procedures may be less likely to benefit.

What this research studies

This grant focuses on a novel treatment strategy for cancer-associated cachexia, a debilitating condition that worsens quality of life and survival in patients with advanced cancers. Researchers have identified vagal overactivity as a driver of cachexia and are testing a non-invasive, transcutaneous vagal block to halt or reverse weight loss and muscle loss in preclinical models, with the aim of translating it to patients. The project explores how this approach works with chemotherapy to boost effectiveness and survival, using sophisticated animal models and plans for human studies. If successful, the therapy could become a safe adjunct to existing cancer care, helping patients eat better, stay stronger, and tolerate treatment longer.

Why it matters

Potential benefit: If successful, this treatment could improve appetite and muscle mass, reduce treatment toxicity, and extend survival for people with advanced cancer experiencing cachexia.

How similar studies have gone: Preclinical work has shown that targeting the brain–liver axis with non-invasive vagal interventions can prevent or reverse cachexia in cancer models.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Shen, Xiling — University of Tx Md Anderson Can Ctr
  • Study coordinator: Shen, Xiling

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • CANCAN: A Virtual Institute to Cure Cancer Cachexia

    A broad, collaborative NIH initiative aims to uncover why cancer patients lose weight and muscle and to develop new ways to treat this serious condition.

    NIH research New York University School of Medicine · New York, United States · NIH-11596283

  • Adipose tissue and its role in lung cancer cachexia

    A new NIH grant explores how fat tissue around the body may feed lung cancer growth and drive weight loss, with the aim of finding ways to help patients who struggle with cancer cachexia.

    NIH research University of Vermont & St Agric College · Burlington, United States · NIH-11587408

  • Spatial metabolism mapping in cancer cachexia tissues

    Aims to map where and how metabolism changes in tissues affected by cancer cachexia using advanced imaging technology.

    NIH research Northwestern University · Chicago, United States · NIH-11539627

  • Innate inflammatory control of cachexia in chronic disease

    A research team is studying how inflammation drives cachexia in chronic disease using a parasite model to find therapies that could protect lean body mass without raising infection risk.

    NIH research University of Virginia · Charlottesville, United States · NIH-11508215

  • Nuclear receptors that may stop muscle wasting in cancer

    This grant explores whether activating specific muscle-regulating receptors can prevent muscle loss in cancer patients.

    NIH research University of Texas Hlth Sci Ctr Houston · Houston, United States · NIH-11499527

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.